Christophe Weber, President and CEO | Takeda Pharmaceuticals
Christophe Weber is president, chief executive officer (CEO) and representative director of Takeda. He joined the company in April 2014 as chief operating officer, was named president and representative director in June 2014, and was subsequently appointed CEO in April 2015. Christophe has focused on ensuring the company’s competitiveness through globalization and R&D transformation - all while creating a diverse and inclusive working environment and strengthening Takeda’s ethical values and corporate governance. Through this transformation, Takeda has become one of the leading global biopharmaceutical companies.
Prior to joining Takeda, Christophe spent 20 years at GlaxoSmithKline where he held senior leadership roles in Europe, Asia and the United States.
Christophe is a member of The US Business Council, the World Economic Forum’s International Business Council, the New York Stock Exchange’s NYSE Board Advisory Council, the Massachusetts Competitive Partnership’s Board of Directors, the MIT CEO Advisory Board and Singapore’s Human Health & Potential International Advisory Committee. He also serves on the Board of Trustees of Northeastern University.
Christophe holds a doctorate in pharmacy and pharmacokinetics, master’s degrees in pharmaceutical marketing and accounting and finance, and a degree in statistics from the University of Lyon, France.
Christophe lives in Tokyo and Boston with his wife and has two children.